Clinical Trial Update: Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical study evaluating Nesiritide in patients undergoing CABG surgery that has completed. The trial status is finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Coronary Artery Bypass Surgery, Coronary Heart Disease | Phase 2 | Status: COMPLETED